Clinical trials
Phase 4 HIV Infections trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2021 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Terminated | 2 |
| Unknown status | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 4 |
| Oswaldo Cruz Foundation | 4 |
| Fred Hutchinson Cancer Center | 1 |
| Hospital Nossa Senhora da Conceicao | 1 |
| International Maternal Pediatric Adolescent AIDS Clinical Trials Group | 1 |
| Johns Hopkins University | 1 |
| Kirby Institute | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
| Stanford University | 1 |
| UPECLIN HC FM Botucatu Unesp | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| HIV Infections | 21 |
| Tuberculosis | 5 |
| Acquired Immunodeficiency Syndrome | 3 |
| Arthritis, Rheumatoid | 1 |
| COVID-19 | 1 |
| Coinfection | 1 |
| Hepatitis B | 1 |
| Lupus Erythematosus, Systemic | 1 |
| Rheumatic Diseases | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.